Go Pro
OTCMKTS:EBOSF

EBOS Group (EBOSF) Stock Price, News & Analysis

EBOS Group logo
$23.75 0.00 (0.00%)
As of 09/10/2026

About EBOS Group Stock (OTCMKTS:EBOSF)

Advanced

Key Stats

Today's Range
$23.35
$23.75
50-Day Range
$23.75
$23.75
52-Week Range
$20.02
$23.75
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

EBOS Group (OTCMKTS:EBOSF) is a leading distributor of healthcare and animal care products and services in Australia and New Zealand. The company operates through two primary divisions: Healthcare, which supplies pharmaceuticals, medical consumables, diagnostic and surgical equipment to hospitals, pharmacies and aged‐care facilities; and Animal Care, which provides veterinary medicines, nutrition and equipment to veterinary clinics, farmers and pet specialty outlets.

In its Healthcare division, EBOS Group offers a comprehensive range of prescription and over‐the‐counter medicines, medical devices and consumer health products. The business supports retail pharmacy networks, hospital supply chains and allied health professionals with value‐added services such as procurement, logistics, product training and regulatory support. Through Animal Care, the company distributes a portfolio of veterinary pharmaceuticals, vaccines, diagnostics and nutrition products, alongside equipment and consumables for livestock and companion animals.

Tracing its roots to a small pharmaceuticals wholesaler established in the early 1920s in New Zealand, EBOS Group has grown through a series of strategic acquisitions and organic expansions. The company is headquartered in the Australia–New Zealand region and maintains an extensive network of distribution centres, warehousing facilities and service locations across both countries. This regional footprint enables EBOS to deliver timely logistics and local support to its diverse customer base.

EBOS Group is governed by an experienced board of directors and led by an executive management team with deep expertise in healthcare distribution and animal health. The company continues to pursue growth opportunities through selective acquisitions, infrastructure investment and the development of value‐added solutions aimed at enhancing supply chain efficiency and customer outcomes.

AI Generated. May Contain Errors.

Receive EBOSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EBOS Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EBOSF Stock News Headlines

EBOS Group Reports Lapse of 326,623 Performance Rights
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
EBOS Updates Market on Lapse of Performance Rights
See More Headlines

EBOSF Stock Analysis - Frequently Asked Questions

EBOS Group's stock was trading at $23.75 at the beginning of the year. Since then, EBOSF stock has increased by 0.0% and is now trading at $23.75.

Shares of EBOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:EBOSF
CIK
1533082
Fax
N/A
Employees
5,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:EBOSF) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners